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Functional network topology in drug resistant
and well-controlled idiopathic generalized
epilepsy: a resting state functional MRI study
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Rajiv Mohanraj,1,2 Jason R. Taylor2,7 and Simon S. Keller3
Despite an increasing number of drug treatment options for people with idiopathic generalized epilepsy (IGE), drug resistance remains
a significant issue and the mechanisms underlying it remain poorly understood. Previous studies have largely focused on potential cel-
lular or genetic explanations for drug resistance. However, epilepsy is understood to be a network disorder and there is a growing
body of literature suggesting altered topology of large-scale resting networks in people with epilepsy compared with controls. We hy-
pothesize that network alterations may also play a role in seizure control. The aim of this study was to compare resting state func-
tional network structure between well-controlled IGE (WC-IGE), drug resistant IGE (DR-IGE) and healthy controls. Thirty-three par-
ticipants with IGE (10 with WC-IGE and 23 with DR-IGE ) and 34 controls were included. Resting state functional MRI networks
were constructed using the Functional Connectivity Toolbox (CONN). Global graph theoretic network measures of average node
strength (an equivalent measure to mean degree in a network that is fully connected), node strength distribution variance, characteris-
tic path length, average clustering coefficient, small-world index and average betweenness centrality were computed. Graphs were
constructed separately for positively weighted connections and for absolute values. Individual nodal values of strength and between-
ness centrality were also measured and ‘hub nodes’ were compared between groups. Outcome measures were assessed across the three
groups and between both groups with IGE and controls. The IGE group as a whole had a higher average node strength, characteristic
path length and average betweenness centrality. There were no clear differences between groups according to seizure control.
Outcome metrics were sensitive to whether negatively correlated connections were included in network construction. There were no
clear differences in the location of ‘hub nodes’ between groups. The results suggest that, irrespective of seizure control, IGE interictal
network topology is more regular and has a higher global connectivity compared to controls, with no alteration in hub node loca-
tions. These alterations may produce a resting state network that is more vulnerable to transitioning to the seizure state. It is possible
that the lack of apparent influence of seizure control on network topology is limited by challenges in classifying drug response. It is
also demonstrated that network topological features are influenced by the sign of connectivity weights and therefore future methodo-
logical work is warranted to account for anticorrelations in graph theoretic studies.
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Introduction
Epilepsy affects around 70 million people worldwide,1 of
whom 15–20% are estimated to have idiopathic general-
ized epilepsy (IGE).2 IGEs comprise a group of syn-
dromes characterized by the occurrence of generalized
seizures in the absence of neurodevelopmental abnormal-
ities or structural brain lesions.3 Approximately 18% of
people with IGE do not become seizure-free despite an
adequate trial of at least two appropriate and tolerated
antiepileptic drugs (AEDs).4,5 Subsequent changes to drug
regimens have a low chance of resulting in seizure free-
dom6 and, therefore, such patients are considered to have
drug resistant epilepsy.7 In addition to a high seizure bur-
den, people with drug resistant epilepsy have a higher
rate of injury,8 sudden unexplained death in epilepsy,9
and social difficulties,10 compared with those with con-
trolled seizures.
Traditionally, drug resistance in epilepsy has been
examined from a cellular or genetic perspective.
However, such approaches have failed to fully explain
the underlying mechanisms of drug resistance.11 Since epi-
lepsy is now understood to be a network disorder, in
which seizures emerge from the dynamic resting state of
the brain,12 investigating epilepsy drug resistance from a
resting state network perspective may facilitate greater
understanding of this important issue.
Resting state brain networks may be examined using
functional MRI (fMRI), whereby blood oxygen level de-
pendent (BOLD) signal is statistically analysed to
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establish the extent of connectivity between regions.
Graph theory provides a robust mathematical method to
subsequently delineate and analyse network topology
(structure). Within this framework, each brain area is
termed a ‘node’ and the connections between nodes are
termed ‘edges’. Edges may be weighted according to the
strength of correlation of BOLD signal between nodes.
Information regarding the presence and strength of pairs
of connections within a network is contained within a
connectivity matrix and from this, a range of network
metrics and features can be determined (Table 1).13,14
Overall evidence from graph theoretical studies derived
from electroencephalography (EEG), magnetoencephalog-
raphy (MEG) and MRI suggests that networks of people
with focal epilepsy and IGE have a more regular top-
ology compared with controls.15,16 It has been proposed
that this regularity may render the network more likely
to synchronize than a network that has a more random
structure.17 However, there are inconsistencies within the
literature, with some studies consistent with a more
random network structure in epilepsy and others not
identifying any differences in network regularity.18–20
To our knowledge, analysing fMRI-derived functional
connectivity from a global network perspective in IGE
according to seizure control has not previously been con-
sidered. However, reduced connectivity in specific net-
works (cerebellar and default mode networks) in drug
resistant IGE (DR-IGE) compared with well-controlled
IGE (WC-IGE) has been described.21,22 In an EEG top-
ology study by our group, in a different patient cohort,
differences were found between controls and WC-IGE in
the 10–12 Hz frequency band (compared with controls,
mean degree and degree distribution variance was lower
in WC-IGE and small world index was higher).23 This
perhaps suggests that in people who respond to medica-
tion, drug-induced alterations to the network render the
network less susceptible to seizures.
Considering that network topology may play a role in
seizure control in IGE, and that diverging findings in the
literature of IGE network topology may be influenced by
Table 1 Commonly used graph theoretical terms and measures applied to epilepsy research
Node (vertex) (n) The unit which forms a graph and represents an underlying brain
region
Edge Connection between two nodes
Directed edge Information flows in one direction only
Undirected edge Information flows in either direction
Weighted edge A value given to an edge according to the strength of the connection
Degree distribution variance/node strength distribution variance The variance of the node degree/node strength distribution
Degree (k) Number of connections of a node
Node strength The summed strength of connections of a node in a fully connected net-
work. This is an equivalent measure to the node degree.
Nodes with a high number of connections or a high connectivity strength
may be regarded as ‘hub nodes’
The mean value of the node strength values of all network nodes
Average node strength
Clustering coefficient (C) The probability that the neighbouring nodes of a given node are them-
selves connected
C is averaged to calculate the clustering coefficient of the whole graph. (A
measure of network segregation)
Mean clustering coefficient (Ci)
Path length (d) Minimum (or shortest) number of edges connecting 2 nodes
Mean of the shortest path length between all pairs of network nodes (a
measure of network integration)
Characteristic path length (L)
Small-worldness Ratio of average clustering coefficient of the graph to the mean clustering
coefficient of a similar size random graph as a proportion of the ratio of
the characteristic path length of the graph compared with the path
length of a random graph
[C/C random]
[P/P random]
Small-world networks have higher than expected clustering coefficient
with a characteristic path length of equal or lower value than a random
graph
Betweenness centrality A measure of to what extent a node lies on all shortest paths between
each pair of network nodes.
A measure of the importance of a node within the network. Nodes with
high betweenness centrality may be regarding as ‘hub nodes’
The mean value of the betweenness centrality values of all network nodes
Average betweenness centrality
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a lack of evaluation according to seizure control,16 the
aim of this study was to compare resting state global net-
work topology in people with DR-IGE, WC-IGE and
controls, using fMRI. Consistent with the intrinsic sever-
ity hypothesis of drug resistant epilepsy, where the inher-
ent severity of epilepsy determines medication response,24
we hypothesize that network aberrations in epilepsy lie
on a spectrum according to seizure control, with altera-
tions in WC-IGE lying between those of DR-IGE and
controls. We also tested the hypothesis that specific nodes
which play a prominent role in network integration (so-
called ‘hub nodes’), differ between people with IGE and
controls.18,25 The potential importance of hub nodes in
seizure susceptibility in focal epilepsy is well




Thirty-five participants with IGE were recruited from the
Walton Centre NHS Foundation Trust and from Salford
Royal NHS Foundation Trust. All participants with IGE
had been diagnosed by an experienced epileptologist accord-
ing to current International League Against Epilepsy (ILAE)
criteria 3 based on patient history, seizure semiology and
EEG. Two participants were subsequently excluded. This
was due to the re-classification of epilepsy type in one case
and in the other, there was an MRI finding of focal cortical
dysplasia (this was an incidental finding, the syndromic
classification of IGE remains following review of diagnosis).
Twenty-three participants had DR-IGE (persistent seizures
despite AED treatment) and 10 were seizure-free for at least
one year and therefore were classified as having WC-IGE.
Thirty-four healthy controls were recruited locally from the
University of Liverpool and the general public. None of the
participants was familiar with the scanning environment.
Informed, written consent was obtained for all partici-
pants according to the Declaration of Helsinki and this
study was approved by the local ethics committee (UK
Research Ethical Committee reference 14/NW/0332).
Data collection and pre-processing
3D T1-weighted and resting state fMRI (RS-fMRI) images
were obtained for each participant using a 3T GE
Discovery MR 750 MR system. Scanning was performed
supine in the head-first orientation. Participants were
instructed to stay awake and to look at a white fixation
cross on a black background. T1-weighted data were
acquired using the following parameters: Pulse sequence ¼
BRAVO; echo time (TE) ¼ 3.22 ms; repetition time (TR) ¼
8.2 ms; field of view (FOV) ¼ 24, TI ¼ 450 ms; slice thick-
ness ¼ 1 mm; voxel size ¼ 1 mm  1 mm  1 mm; 140
slices; flip angle ¼ 12. RS-fMRI was obtained with a 6-
min3 T2-weighted sequence with the following parameters:
Pulse sequence ¼ gradient echo; TE ¼ 25 ms; TR ¼
2000 ms; FOV ¼ 24; slice thickness ¼ 2.4 mm; voxel size
¼ 3 mm  3 mm  3 mm; 180 volumes; 38 slices; flip
angle ¼ 75.
Spatial pre-processing was implemented in SPM12
using the standard SPM pipeline. Slice timing correction
of the fMRI time series was performed using the first
slice as the reference. Head motion and EPI distortion
were corrected to the first functional volume. The esti-
mated movement parameters (3 translation; 3 rotation)
were saved and later included as covariates for each sub-
ject in the first level analysis to produce the connectivity
matrix. Data were normalized into MNI (Montreal
Neurological Institute) space using the ICBM 152 tem-
plate of European brains28; the mean functional image
was registered to the template image via a direct affine
and interpolated into 2  2  2 mm voxel space using
4th-degree B-Spline method. The resulting warp param-
eter was then applied to all volumes. Gaussian kernel
smoothing with an 8 mm full width half-maximum
Gaussian kernel was employed at each data point and
neighbourhood voxel. Tissue segmentation was performed
using the SPM add-on CAT12 toolbox (http://www.
neuro.uni-jena.de/cat/. Last accessed 18/05/21). This spa-
tially normalizes the T1-weighted image into the MNI
space then segments it into skull-stripped brain.
Following this, adaptive maximum a posteriori segmenta-
tion29 was performed to quantify estimates of grey mat-
ter, white matter and cerebrospinal fluid present at each
element. An exclusion threshold for motion >3 mm trans-
lation and >1 rotation was set.30
Spatially pre-processed data were next temporally pre-
processed using the Functional Connectivity Toolbox
(CONN).31 Component-based noise correction using the
CompCor method32 was performed to reduce voxel spe-
cific noise, including noise arising from cardiac pulsations
and respiratory modulations. Potential confounds from
white matter and cerebrospinal fluid (based on principal
component analysis of the multivariate BOLD signal
within masks produced from T1-weighted tissue segmen-
tation for each subject) were added as covariates in
CONN. Head motion effects that were detected in spatial
pre-processing (6 estimated movement parameters per vol-
ume) were used as covariates to further reduce noise.
These steps are reported to increase the sensitivity of
results of both correlated and anticorrelated networks.31
Furthermore, white matter and cerebrospinal fluid com-
partments were entered as covariates to reduce partial
volume effects. Bandpass filtering was also implemented
to further remove physiological noise and to limit BOLD
to between 0.01 and 0.08 Hz. Networks within this fre-
quency range are widely reported to represent the resting
state of the brain.31,33–35
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Network construction
Weighted functional connectivity matrices were con-
structed using the CONN functional connectivity toolbox
(Fig. 1). Data were parcellated using AICHA (Atlas of
Intrinsic Connectivity of Homotopic Areas).36 This func-
tional resting state connectivity atlas segregates data into
384 regions comprising 244 gyral regions, 100 sulcal
regions and 40 grey matter nuclei. Network edges were
defined using a weighted least squares linear model,
where Pearson’s correlation of average BOLD signal was
determined between each pair of regions, with the
strength of correlation forming the weight. This was
Fisher transformed to provide normally distributed scores,
producing Z, representing the weighted matrix of Fisher
transformed correlation coefficients.
Weighted, undirected, graphs were subsequently con-
structed using a custom script implemented in Matlab.37
Thresholding was performed in order to improve sensitivity
to physiologically relevant connections versus noise,13 with
connections with weights between 0.25 and þ 0.25
excluded. There is no universally agreed threshold value,
with variations from r¼ 0.1 to r¼ 0.8 seen in the litera-
ture.38 A threshold of r¼ 0.25 was selected as it is a com-
monly used threshold.39 A post hoc analysis explored the
effects of altering the threshold by performing the analysis
with thresholds of zero, r¼ 0.125, and r¼ 0.375. There is
no optimal solution to handle negative values in graph the-
oretical analysis40; typically either positively correlated val-
ues or absolute values are used.41 The rationale for
discarding negatively correlated edges comes from studies
demonstrating that anticorrelated networks reflect artefact
generated in pre-processing.42,43 However, there is also evi-
dence to suggest that anticorrelated networks have an im-
portant role in brain functioning44,45 and as such, relevant
connectivity information may be overlooked if negative cor-
relations are ignored.40 In view of this debate, and the fact
that graph theoretic measures cannot account for signed
weights, two separate analyses were performed for global
metrics; one based on networks created from only positive
correlations, and the other using absolute correlations.
Figure 1 Schematic overview of study methodology. After data were collected and pre-processed, parcellation into network nodes
was performed. Connectivity matrices were constructed for each participant. Graphs were created for each participant in each group,
followed by group-level statistical analysis.









niversity of Liverpool user on 06 Septem
ber 2021
Graph analysis
Global measures of average node strength, node strength
distribution variance, average clustering coefficient, char-
acteristic path length, small-world index and average
betweenness centrality were calculated. These metrics
were chosen to provide a broad overview of network
topology. Because clustering coefficient and characteristic
path length are sensitive to degree, normalized metrics
were calculated for each by dividing average clustering
coefficient and characteristic path length by the mean of
the clustering coefficient and characteristic path length
distributions of 500 surrogate random networks
respectively.46,47
As a post hoc analysis, strength and betweenness cen-
trality were also calculated for each node individually
using an edge threshold of 0.25. Subsequently, ‘hub
nodes’ were identified for each participant. Nodes were
considered as hubs if both strength and betweenness cen-
trality were greater than one standard deviation above
the corresponding mean network value.48–50 The nodal
metric analysis was carried out using absolute values
only, and compared IGE with controls, in view of the
results of the global network analysis.
Statistical analysis
Demographic and outcome metric results were firstly
assessed for normality (by reviewing kurtosis, skewness,
histograms and Q–Q plots). Next, potential differences in
demographics and outcome metrics between the three
groups were evaluated using Kruskal–Wallis tests or one-
way analysis of covariance, as appropriate. Age and epi-
lepsy duration were included as co-variates. Where differ-
ences were found, pairwise comparisons were evaluated
using a Mann–Whitney U- or Tukey test. This was
Bonferroni corrected for multiple comparisons using a
factor of six. In addition, both groups with epilepsy were
combined into one cohort and global outcome metrics
were compared with controls using an independent t-test,
controlled for participant age.
Potential differences in connectivity between individual
nodes in IGE compared with controls were evaluated by
comparing the strength and betweenness centrality of
each node, using a Mann–Whitney U-test. Correction for
multiple comparisons was implemented using the false
discovery rate (FDR)51 with a q-value of 0.1. Following
the identification of hub nodes, the total number of times
a node was considered a hub in each group was calcu-
lated and displayed visually. The number of hub nodes in
each group was compared using a Kruskal–Wallis test.
An analysis to compare motion parameters between the
participants with IGE and controls was performed.
Normality of the data was tested first using a Lilliefors
test and when significant (P< 0.05) a Mann–Whitney U-
test was performed.
Data availability statement
The data that support the findings of this study are avail-
able on request from the corresponding author. The ori-




Median age significantly differed between groups (DR-
IGE ¼ 31 years; WC-IGE ¼ 22.5 years; Controls ¼
32 years (Table 2). Kruskal–Wallis H¼ 8.02,
P¼ 0.018). Pairwise comparisons found a difference in
age between WC-IGE and controls (P¼ 0.014), with no
significant differences between WC-IGE and DR-IGE
(P¼ 0.094), DR-IGE and controls (P¼ 1.00), or be-
tween both IGE groups (combined) and controls
(P¼ 0.066). Females comprised 59.7% of participants,
with no significant difference across groups (Pearson
Chi-square ¼ 0.84, P¼ 0.656). Median duration of epi-
lepsy was 14.5 years in DR-IGE and 6.5 years in WC-
IGE. This difference was not statistically significant
(Kruskal–Wallis H¼ 2.715, P¼ 0.099). The mean num-
ber of AEDs taken in the group with WC-IGE was
1.14 (range 1–2) and in the DR-IGE group was 1.9
(range 1–4). This difference was not statistically signifi-
cant (Mann–Whitney U¼ 1.937, P¼ 0.524).
There was no significant difference in average root
mean square motion values between groups (Mann–
Whitney U¼ 1197, mean controls ¼ 0.27, mean IGE ¼
0.33, P¼ 0.48).
Global outcome metrics
In the graphs constructed using absolute values at a
threshold of 0.25 (Supplementary Tables 1–3), there was
a difference between the three groups in average between-
ness centrality (one-way ANOVA F¼ 4.657, P¼ 0.013).
Pairwise comparisons identified a significantly higher
average betweenness centrality in WC-IGE compared
with controls (P¼ 0.048) and a possible trend towards a
significantly higher average betweenness centrality in DR-
IGE compared with controls (P¼ 0.057), with no differ-
ence between WC-IGE and DR-IGE (P¼ 1). There were
no other differences in global metrics at the three-group
level. When both IGE groups (WC-IGE and DR-IGE
combined) were compared with controls, a higher average
node strength (Fig. 2a) and average betweenness central-
ity (Fig. 2f) were found in the group with IGE (respect-
ively; t¼ 5.956, P¼ 0.017; t¼ 8.963, P¼ 0.004). A trend
toward a significantly higher characteristic path length
(Fig. 2d) and lower small-world index (Fig. 2e) was seen
in IGE (respectively; t¼ 3.864, P¼ 0.054; t¼ 3.787,
P¼ 0.056). There were no differences in node strength
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distribution variance (Fig. 2b) or clustering coefficient
(Fig. 2c) between the two groups.
In the graphs constructed using positively correlated
edges only, using a threshold of 0.25, there were no
significant results at the three-group level. A higher
average node strength (Fig. 2g) and greater characteris-
tic path length (Fig. 2j) was identified in IGE (WC-IGE
and DR-IGE combined) compared with controls (re-
spectively; t¼ 6.200, P¼ 0.015; t¼ 4.717 P¼ 0.034).
The remaining outcome metrics did not significantly
differ between the two groups (Fig. 2h, j–l).
There was no correlation between age or epilepsy dur-
ation with any outcome metric (Pearson’s correlation
P> 0.05 in all comparisons).
When edge thresholds of zero, 0.125, and 0.375 were
tested, the finding of a statistically higher average node
strength in the IGE group (WC-IGE and DR-IGE com-
bined) compared with controls was robust across all
thresholds and for networks constructed with both abso-
lute edge values (respectively; P¼ 0.08, P¼ 0.02,
P¼ 0.015) and positive edge values (respectively;
P¼ 0.019, P¼ 0.018, P¼ 0.011). As with the threshold
level of 0.25, higher characteristic path length and greater
average betweenness centrality were also found in net-
works constructed with an edge threshold of 0.375 (re-
spectively; P¼ 0.039, P¼ 0.041). Additionally, small
world index was lower in IGE than controls using a
threshold of 0.375 (using absolute edge values,
P¼ 0.034) and with positive edges without a threshold
(P¼ 0.035). Clustering coefficient was higher in IGE com-
pared with controls with a threshold of 0.375 (using
positive edge values, P¼ 0.011). No other significant











4 WC-IGE 25 M 19 MJ Levetiracetam 1500 mg, valproate 1600 mg Typical
18 WC-IGE 24 F 16 Abs, GTC Valproate 1000 mg, lamotrigine 200 mg, levetirace-
tam 4000 mg
Typical
23 WC-IGE 23 M 16 Abs, GTC Valproate 2100 mg, levetiracetam 500 mg Typical
24 WC-IGE 19 F 13 GTC Levetiracetam 3000 mg NA
26 WC-IGE 18 F 15 Abs, eyelid myoclonus Levetiracetam 2000 mg Typical
27 WC-IGE 22 M 2 Abs, MJ Valproate 1400 mg NA
29 WC-IGE 56 F 3 Abs Valproate 1500 mg NA
31 WC-IGE 33 M 7 Abs Valproate 1800 mg Typical
32 WC-IGE 19 F 14 Abs, MJ Levetiracetam 1000 mg NA
34 WC-IGE 20 M 16 Abs, MJ, GTC valproate 1700 mg, ethosuxamide 500 mg Typical
1 DR-IGE 23 F 14 Abs, MJ Levetiracetam 3000 mg, topiramate 300 mg, cloba-
zam 10 mg
Typical
2 DR-IGE 19 M 16 IGE Valproate 1000 mg Typical
3 DR-IGE 19 F 8 GTC, Abs Lamotrigine 200 mg Normal
5 DR-IGE 60 F 13 GTC, Abs Valproate 2500 mg Typical
6 DR-IGE 24 M 15 GTC, MJ, abs Levetiracetam 3000 mg, valproate 2500 mg, carba-
mazepine 1000 mg
Typical
7 DR-IGE 21 F 15 GTC, MJ, abs Levetiracetam 4000 mg, valproate 2000 mg Typical
8 DR-IGE 32 F 23 GTC, MJ Levetiracetam 3500 mg, clobazam 15 mg Normal
9 DR-IGE 38 M 18 GTC, MJ Valproate 600 mg, lamotrigine 50 mg Typical
10 DR-IGE 67 M 29 GTC, Abs Valproate 2000 mg, lamotrigine 200 mg, clobazam
10 mg, phenobarbital 150 mg
NA
11 DR-IGE 46 F 7 Abs Valproate 1200 mg, lamotrigine 200 mg, levetirace-
tam 2500 mg
Normal
13 DR-IGE 20 M 8 GTC, Abs Valproate 2000 mg Typical
14 DR-IGE 24 F 13 GTC, MJ Topiramate 100 mg NA
15 DR-IGE 35 M 6 GTC Levetiracetam 2000 mg, valproate 2000 mg Typical
16 DR-IGE 18 M 14 GTC, Abs Valproate 1500 mg, zonisamide 350 mg Typical
17 DR-IGE 39 M 17 GTC Lamotrigine 75 mg Typical
19 DR-IGE 21 M 16 GTC, abs, MJ Valproate 2400 mg NA
20 DR-IGE 36 F 17 GTC Levetiracetam 1250 mg, lamotrigine 75 mg Typical
21 DR-IGE 31 F 15 GTC Levetiracetam 2000 mg, lamotrigine 400 mg Normal
22 DR-IGE 31 F 16 GTC, MJ, Abs Valproate 1500 mg, levetiracetam 3500 mg Typical
25 DR-IGE 58 F 15 GTC, Abs Valproate 1000 mg, zonisamide 400 mg, clonazepam
1.5 mg
Typical
28 DR-IGE 24 M 13 MJ, abs Valproate 1700 mg Typical
30 DR-IGE 57 F 7 GTC, abs Valproate 1200 mg, carbamazepine 600 mg Typical
33 DR-IGE 57 F 7 GTC, abs Valproate 2000 mg, lamotrigine 75 mg Typical
abs, absence; F, female; GTC, generalized tonic-clonic; M, male; MJ, myoclonic jerk; NA, not available; normal, normal interictal EEG; typical, interictal EEG findings consistent with
IGE.
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differences were found in other group comparisons. Full
details of results across various thresholds can be found
in Supplementary Table 3.
Nodal outcome metrics
Neither betweenness centrality nor node strength sur-
vived correction for multiple comparisons
(Supplementary Tables 4 and 5). This was an explora-
tory study with 384 comparisons and therefore, results
of uncorrected significant results, which may suggest a
trend towards significance, are presented together with
effect sizes.52 Uncorrected significant differences in
betweenness centrality and node strength at the level of
individual nodes between the IGE group and controls
were found in 37 and 35 nodes respectively. Node
strength was higher in IGE in each of the 35 nodes
(Fig. 3A), whereas there was a greater betweenness cen-
trality at some of the 37 nodes in IGE and a lower
value in others (Fig. 3B).
The median number of hub nodes in each group was
38 and there was no significant difference in the total
number of hub nodes between each group, in either the
three group or two group comparison (respectively;
Kruskal–Wallis U¼ 0.593, P¼ 0.743; Mann–Whitney
U¼ 617, P¼ 0.671). On inspection of plots of the fre-
quency of hub nodes at each location, there were no
clear group differences between the location of hub
nodes (Supplementary Table 6, Figs. 1–5).
Discussion
This study investigated global RS-fMRI network features
in people with DR-IGE, WC-IGE and healthy controls.
Figure 2 Global outcome metrics. (A) Networks constructed using absolute values of edges. (B) Networks constructed using positively
correlated edges. Data are plotted for IGE (WC-IGE and DR-IGE combined) and controls. *Statistically significant difference between groups
(P< 0.05).
Figure 3 Nodal differences between IGE and controls. This
illustrates the location of nodes that have significantly different
uncorrected outcome metrics. (A) Node strength and (B)
betweenness centrality. Red dots indicate a higher value in IGE,
blue dots represent a lower value in IGE. L ¼ left side of brain; R ¼
right side of brain. This figure was created using BrainNet Viewer.53
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The results suggest that compared with controls, network
topology in IGE is less integrated and more regular (as
evidenced by a higher path length) and has generally
greater connectivity across the network nodes (demon-
strated by a higher average node strength and average
betweenness centrality), without a clear difference in the
location of hub nodes. Network topology did not vary
according to seizure control.
A higher characteristic path length results in a more
regular network topology.54 It has been suggested that a
regular configuration may render a network more vul-
nerable to synchronization.15 The finding of a higher
characteristic path length in IGE, is consistent with the
findings from a meta-analysis of functional connectivity
studies in focal epilepsy using fMRI and EEG,15 and in
structural studies in IGE.19,55,56 However, in the two
fMRI-derived functional connectivity studies18,57 identi-
fied in our systematic review,16 there was no difference
in characteristic path length between people with IGE
and controls. However, in both previous studies, net-
works were constructed using absolute correlations
whereas the finding of altered characteristic path length
in the present study was in positively correlated net-
works. In these same studies, also in contrast to the pre-
sent study, one reported a lower clustering coefficient
and small-world index in IGE,18 and the other reported
a higher small-world index in IGE.57 Average between-
ness centrality and average node strength were not con-
sidered in these two studies. An important difference in
our study compared with both of these studies is the
method by which data were parcellated into nodes; in
our study, a functional connectivity atlas was used,
whereas the others used an anatomical atlas. It is known
that the technique of data parcellation may affect con-
nectivity measures58 and as such this is an important
methodological decision. In functionally derived data
parcellation schemes, nodes comprise components with
similar temporal activation patterns. As such, it is sug-
gested that such atlases are particularly suitable for
functional connectivity analysis as the nodes reflect func-
tionally coherent areas.59–61
The average node strength of a network reflects the
strength of connections of each node across the network.
Therefore, networks that have a higher average node
strength perhaps reflect networks with generally greater
connectivity. Similarly, networks with higher average
betweenness centrality (a measure of the extent of ‘infor-
mation flow’ within a network), may also reflect a
greater resting state hyperexcitability of the epileptic
brain.62 There are limited studies within the IGE litera-
ture that have considered these metrics. Increased average
betweenness centrality, average node strength, or mean
degree have been reported in at least two EEG/MEG
studies.63,64 However, other studies have reported no dif-
ference between groups,65 or a decreased value55 It
should be noted that the comparison between fMRI and
EEG/MEG is challenging owing to their different
sensitivities to temporal and spatial resolution, which
may account for diverging findings.16
Post hoc analysis of global metrics using a range of
edge thresholds showed that the results were robust for
average node strength and for betweenness centrality at
higher threshold values. The additional significant find-
ings of increased clustering coefficient in IGE and lower
small world index were also in support of a more regular
network topology in IGE.
When the results using different thresholds of edges are
compared, it is evident that the choice of threshold can
alter the results. There appears to be a relationship be-
tween higher threshold values and the detection of a
greater number of statistically significant results.
Thresholds are applied to edges with the aim of decreas-
ing sensitivity to spurious connections, but the optimal
method to achieve this aim is not known. It is important
to note that networks with lower summed synchroniza-
tion values will become relatively less dense than net-
works with higher overall synchronization values after
thresholding.41 This is a potential limitation since it is
known that network density may affect some network
metrics (particularly clustering coefficient and characteris-
tic path length).66 This issue could potentially be over-
come by constructing matrices that have the same
number of connections in each network. However, this
approach may result in networks with overall low con-
nectivity producing fewer significant connections whilst
potentially important connections in higher density net-
works may be disregarded.66
The additional findings depending on whether negative-
ly correlated edges were discarded highlight that network
topology is sensitive to the sign of the edge. As discussed
above, the significance of anticorrelated networks and the
extent to which they are influenced by pre-processing
techniques are not fully elucidated. We suggest that by
using absolute values, correlation values may be regarded
as a reflection of the strength of neural connectivity, irre-
spective of the nature of the relationship. The similarity
of results of both analyses suggests that the results are
not confounded by taking into account negative correla-
tions and in fact, their inclusion may improve sensitivity
to the detection of network differences. How negative
correlations may be mathematically accounted for in
graph theoretic analysis is an important consideration for
future graph theoretical studies.
Previous fMRI connectivity studies have reported wide-
spread locations of specific nodes that display altered
connectivity in IGE, with a similar location of hub nodes
in IGE and controls.18,57 Both studies corrected for mul-
tiple comparisons using the FDR, but the threshold used
is unclear. In Liao et al.’s study, significance levels did
not survive this correction. Notwithstanding the fact that
the individual nodal comparisons did not survive correc-
tion for multiple comparisons in our study, there is no
suggestion from our study or from these previous studies,
that there are specific regions of altered resting state
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connectivity in IGE. Whilst corticothalamic regions have
been implicated in seizure genesis, it is possible that in
generalized seizure disorders, the precise area of network
aberration from where a seizure is initiated may vary be-
tween, or within, individuals.67
It is possible that differences in network features in the
group with IGE compared with controls represent medi-
cation effects. Previous studies have described alterations
in global efficiency (inverse of characteristic path length)
with topiramate, but not with valproate, lamotrigine or
levetiracetam.68 Another study reported altered between-
ness centrality (but not other network metrics) with
carbamazepine, but not with other commonly used
AEDs.69 Therefore, overall, there is no strong evidence
that medication effects directly explain the results. The in-
clusion of a group with epilepsy not taking an AED
would help clarify this, but this would be practically dif-
ficult since AEDs are typically started at diagnosis.
This study did not find any differences in network top-
ology dependent upon seizure control. One limitation of
this interpretation is the small sample size, particularly in
the WC-IGE group, which may have been underpowered
to detect a possible difference. The low number of partici-
pants recruited with WC-IGE reflects the fact that they are
less likely to remain under long-term follow up. In addition
to potential underpowering, a small sample size may also
result in a type 1 error.70 Normal values of network met-
rics in healthy controls have not been established, thus per-
forming a power calculation is limited by the lack of a
meaningful parameter to include in such a calculation. The
reliability of our findings would be strengthened by repro-
ducing the results in an independent dataset.
A larger study may have also permitted the comparison
of IGE subtypes. Although there is strong evidence to
support that IGE syndromes share pathophysiological and
genetic relationships,71 it is possible that connectivity fea-
tures vary between subtypes.72 Further studies with larger
sample numbers are needed to explore whether IGE sub-
types have different network features. Larger collabora-
tions between institutions could help increase sample
numbers 73,74 and clarify these areas of uncertainty.
These study groups also differed in terms of age and epi-
lepsy duration (although the latter was not statistically
significant). The inclusion of these factors as covariates in
the statistical analysis guards against confounding, how-
ever, it remains possible that the results were influenced
by these differences.75,76 Though the number of AEDs
taken by each of the IGE groups did not differ statistical-
ly, it is likely that the drug burden is higher in the DR-
IGE group due to generally higher doses and a tendency
towards polypharmacy. As such, this may also confound
potential differences between the groups.
A further potential limitation relates to the difficulties
in classifying response to AEDs; Patients may not be con-
cordant with their antiepileptic medication and therefore
may be inaccurately categorized as drug resistant.
Alternatively, they may have unrecognized co-existent
non-epileptic attacks, which could result in a seemingly
higher seizure frequency. Conversely, there is evidence
that some patients under-report seizures,77 which could
potentially result in an incorrect classification of well-con-
trolled epilepsy. In addition, it is known that a propor-
tion of patients follow a fluctuating course, shifting in
and out of seizure control.5 A larger study may enable
the inclusion of this subgroup as a third category.
Although people who fulfil the ILAE definition of seizure
freedom have a lower risk of seizure recurrence within
the next 12 months 78 and improved quality of life,79 it
should be noted that there are potential issues with
dichotomization of variables such as seizure frequency.80
In future studies, it may be of value to examine network
metrics in relation to time since the last seizure.
A further limitation of this study is that interictal epi-
leptiform discharges (IEDs) in the group with IGE may
have confounded the results. IEDs are associated with co-
localized BOLD activation, in addition to BOLD activa-
tion in distant areas.81 A combined EEG-fMRI study
could overcome this limitation but would considerably
add time, complexity and cost.
Conclusions
In summary, this study demonstrates that the network
topology in IGE is more regular and has higher global
connectivity, with no evidence of systematic alteration in
the location of nodes with high connectivity. This was
found to be the case irrespective of seizure control. We
suggest that examining drug resistance from a network
perspective warrants further exploration in a larger, lon-
gitudinal, multimodal study.
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